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Abstract
Background: General somatic sensation is conveyed to the central nervous system at cranial
levels by the trigeminal ganglion (TG), and at spinal levels by the dorsal root ganglia (DRG).
Although these ganglia have similar functions, they have distinct embryological origins, in that both
contain neurons originating from the neural crest, while only the TG includes cells derived from
the placodal ectoderm.
Results: Here we use microarray analysis of E13.5 embryos to demonstrate that the developing
DRG and TG have very similar overall patterns of gene expression. In mice lacking the POU-
domain transcription factor Brn3a, the DRG and TG exhibit many common changes in gene
expression, but a subset of Brn3a target genes show increased expression only in the TG. In the
wild-type TG these Brn3a-repressed genes are silent, yet their promoter regions exhibit histone
H3-acetylation levels similar to constitutively transcribed gene loci. This increased H3-acetylation
is not observed in the DRG, suggesting that chromatin modifications play a role in cell-specific
target gene regulation by Brn3a.
Conclusion: These results demonstrate that one developmental role of Brn3a is to repress
potential differences in gene expression between sensory neurons generated at different axial
levels, and to regulate a convergent program of developmental gene expression, in which
functionally similar populations of neurons are generated from different embryological substrates.
Background
The generation of cellular diversity in the developing ver-
tebrate nervous system is one of the most complex prob-
lems in biology, and a large number of transcription
factors have been identified that orchestrate neurodevel-
opment and regulate the molecular identity of neurons.
Perhaps the best-studied systems for the establishment of
neuronal phenotypes in vertebrates are the primary input
(sensory) and output (motor) pathways of the peripheral
sensory ganglia, spinal cord, and brainstem. In these
areas, several key transcriptional regulators have been
identified, many of which are members of the basic-helix-
loop-helix (bHLH) and homeodomain transcription fac-
tor classes [1,2].
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The peripheral sensory nervous system is organized ana-
tomically according to the nature of the external informa-
tion reported to the central nervous system (CNS). The
sensory modalities of pain, touch, temperature and prop-
rioception are transduced by sensory neurons innervating
the skin and musculoskeletal structures, and are referred
to as general somatic sensation. Peripheral sensory neu-
rons also convey the senses of taste and hearing, and vis-
ceral sensation, which reports the state of the internal
organs. At spinal levels, general somatic sensation is con-
veyed by the dorsal root or spinal ganglia (DRG), while in
the anterior head and face, these sensory modalities are
mediated by the trigeminal ganglion (TG).
Surprisingly, in spite of the similar functions of the DRG
and TG, these ganglia have rather different embryological
origins. The DRG are formed entirely from spinal neural
crest. In contrast, the TG is formed in part from the oph-
thalmic and maxillo-mandibular placodes originating in
the surface ectoderm, as well as cranial neural crest cells
derived from rhombomere 2, which migrate and con-
dense to form the ganglion [3,4]. The trigeminal system
also includes a population of sensory neurons that reside
outside the anatomical ganglion, the mesencephalic
trigeminal (mesV), the exact origin of which is still some-
what controversial [5,6]. The developmental mechanisms
that lead to the differentiation of functionally similar pop-
ulations of neurons from these different embryological
sources are not well understood.
Transcriptional regulators of sensory development may be
broadly divided into early factors that are essential for
neurogenesis, pan-sensory factors that begin to be
expressed around the time of cell-cycle exit, and late fac-
tors that characterize specific sensory subtypes. In mice,
the proneural bHLH factors Ngn1 and Ngn2 are expressed
transiently from embryonic day 8.5 in cranial sensory pre-
cursors and have been shown to have a crucial role in neu-
rogenesis [7-9]. Around the time of ganglion
condensation and cell cycle exit, beginning at E9.5–10.5,
nearly all sensory neurons at both spinal and cranial levels
co-express the homeodomain transcription factors Brn3a
and Islet1 [1,10]. Later in development, factors associated
with the development of specific sensory subtypes include
the runt family factors Runx1 and Runx3, the variant
homeodomain protein Prrxl1/DRG11, and the Ets family
member Etv1/Er81 [1,11-15].
Studies of Brn3a knockout mice have shown that this fac-
tor is required for correct axon growth, target innervation,
and survival of TG and DRG neurons [16-19]. Microarray
studies of the developing TG of Brn3a null mice have
shown that Brn3a is required for a complex program of
sensory gene expression [20]. In the present study, we
examine the role of Brn3a in sensory neurogenesis at trun-
cal and cranial levels. In normal mice, the developing
DRG and TG have very similar patterns of global gene
expression. The loss of Brn3a expression in the developing
DRG leads to marked changes in the expression of specific
neurotransmitters, receptors, developmental regulators,
mediators of signal transduction, and transcription fac-
tors. Many of these changes are conserved between the TG
and DRG of Brn3a knockout mice, but certain transcripts
are markedly increased only in the cranial ganglia. The
promoter regions of these normally silent but differen-
tially regulated genes are hyperacetylated only in the TG,
which may indicate a latent state of 'expressability' that
can differ between spinal and cranial levels. Thus, a key
developmental role of Brn3a may be to repress potential
differences in gene expression between developing DRG
and TG neurons, and thus promote the generation of
functionally similar populations of neurons from differ-
ent embryological sources.
Results
Global gene expression is highly conserved in sensory 
neurons from different axial levels
To begin to compare the molecular program of sensory
neuron development at spinal and cranial levels, we per-
formed global analysis of gene expression in the develop-
ing DRG and TG. E13.5 was chosen for this comparison
because, at this stage, most of the neurons of the DRG and
TG have exited the cell cycle and have begun to express
definitive markers of neurogenesis. Because sensory neu-
rons have conserved functions at spinal and cranial levels,
we hypothesized that the global pattern of gene expres-
sion in the DRG would be much more similar to the TG
than to other neural tissues. Figure 1 illustrates a compar-
ison of gene expression in the DRG to a replicate analysis
from the same tissue, to the TG, and to the embryonic
neocortex. These results show a high degree of overall sim-
ilarity in gene expression between the sensory ganglia
from different axial levels, and confirm that there is much
greater divergence between the patterns of gene expres-
sion in the DRG and the developing cerebral cortex.
Overall, only a very small fraction of the approximately
44,000 transcripts assayed by the array showed profound
differences in expression between the DRG and TG (Table
1). Significantly more transcripts were uniquely expressed
in the DRG, and seven out of ten of the transcripts with
the highest relative expression in the DRG encoded Hox
transcription factors, an expected finding given the axial
restriction of Hox expression. Several of the other differen-
tially expressed genes revealed in the microarray analysis
could be validated by in situ hybridization (see additional
file 1), although some differences appear to represent
anomalous findings that may be related to factors such as
high expression in peripheral glia (Ednrb, Sostdc1).Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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Aside from the Hox factors, the transcript with the greatest
relative expression in the DRG was Etv1, an Ets-family
transcription factor expressed in 1a muscle spindle affer-
ents [13,21]. Immunofluorescence for Etv1 expression in
the E13.5 DRG confirmed expression in sensory neurons
of large and intermediate size, whilst expression was
entirely absent in the TG at this stage (Figure 2a, b). In
contrast, expression of Runx3, an earlier and more general
marker of proprioceptive neurons [13,14], was noted in
both the DRG and TG at E13.5 (Figure 2c, d).
By E16.5, Etv1 expression could be detected in some neu-
rons of the TG, as well as the DRG. In the DRG, one pop-
ulation of Etv1-expressing neurons displayed large soma
and nuclei consistent with 1a proprioceptors. However, in
the TG nearly all of the Etv1-expressing neurons were of
intermediate size, and large Etv1-positive neurons consist-
ent with 1a proprioceptors were rare. In both the DRG and
the TG, this intermediate-sized and later-developing pop-
ulation of Etv1-expressing sensory neurons could be fur-
ther distinguished from the 1a proprioceptors by the co-
expression of Islet2 (Figure 2e, f).
One distinguishing feature of the TG is that a subset of
neurons that are functionally part of the trigeminal sys-
tem, the mesV, is located within the CNS. Examination of
the mesV in late gestation revealed large sensory neurons
positive for Etv1. These neurons co-expressed a tauLacZ
transgene integrated into the Brn3a locus, and Brn3a is a
known marker of the mesencephalic trigeminal [6]. The
position of these neurons in the caudal midbrain is con-
sistent with the role of some of these neurons as muscle
spindle afferents for the muscles of mastication [22].
Thus, the exclusive expression of Etv1 in the DRG but not
the TG at E13.5 appears to result from a population of
Etv1+, Islet2- proprioceptive neurons that are present in
the DRG but are largely restricted to the mesV at the cra-
nial level.
Brn3a regulates multiple downstream targets in the DRG
To understand the developmental programs regulated by
Brn3a at spinal versus cranial levels, we next analyzed glo-
bal gene expression in E13.5 DRG from Brn3a mutant
embryos and wild-type controls. Tables 2 and 3 summa-
rize the transcripts most increased and decreased at E13.5
in the DRG of Brn3a knockout mice, and a more complete
list appears in additional file 2. In situ hybridization and
immunofluorescence were used to verify altered expres-
sion of several of the target genes (Figures 3 and 4), with
an emphasis on newly identified Brn3a targets and genes
for which expression has not been previously described in
the sensory ganglia.
Most of the Brn3a-regulated genes of known function
have specific roles in neurotransmission, axonogenesis/
synaptogenesis, signal transduction, regulation of devel-
opmental pathways, or transcription. Among mediators
of neurotransmission, multiple glutamate receptors
(Gria3, Gria4, Grik1), a GABA transporter (Slc6a1), a
serotonin receptor (Htr3a) and the neuropeptide somato-
Analysis of global gene expression in embryonic neural tissue Figure 1
Analysis of global gene expression in embryonic neural tissue. Analysis of global gene expression was performed using E13.5 
DRG, E13.5 TG and E16.5 cerebral cortex samples. Only probe sets on the Affymetrix 430A array are shown, and transcripts 
with 'absent' calls in all three samples were excluded from the analysis. (a) Plot of DRG expression versus a replicate DRG 
assay closely approximates a diagonal line indicating equal expression in the two samples. (b) Plot of DRG expression versus 
the TG indicates very similar global gene expression in the two samples, with few points lying far from the diagonal. (c) Plot of 
DRG expression versus the embryonic cerebral cortex indicates a large number of transcripts that are differentially expressed 
between the two samples. Axis is graduated in log10 of scaled signal.Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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Table 1: Transcripts differentially expressed in the DRG and TG
Transcript Symbol Class Fold
Greater expression in the DRG
Homeobox B3 Hoxb32 TX (90.4)
Homeobox A9 Hoxa9 TX (90.2)
Homeobox A5 Hoxa52 TX (44.2)
Etv1; ER81 Etv13 TX (40.2)
Homeobox C8 Hoxc82 TX (38.4)
Homeobox B6 Hoxb6 TX (27.6)
Hoxd4 Hoxd4 TX (16.6)
Follistatin Fst2 Dev (12.9)
Leucine-rich repeat-containing G protein-coupled receptor 6 Lgr6 Other (11.8)
Receptor (calcitonin) activity modifying protein 2 Ramp23 ST 10.9
Ca+ channel, L type, alpha 1C subunit Cacna1c NT 9.2
Homeobox B8 Hoxb8 TX (9.1)
BTB and CNC homology 2 Bach2 TX (8.8)
Sclerostin domain containing 1 Sostdc1 Dev 8.5
Laminin, alpha 2 Lama2 Other (7.3)
Selected
Purkinje cell protein 4 Pcp4 Unk (5.7)
LIM domain binding 2 Ldb22 TX 5.6
Zinc finger protein of the cerebellum 1 Zic12 TX 5.3
Gap junction membrane channel protein alpha 1 Gja12 NT 5.1
Protein tyrosine phosphatase, receptor type, E Ptpre3 ST 5.0
Early B-cell factor 1; Olf1 Ebf1 TX 5.0
U74 array
Regulator of G-protein signaling 4 RGS4 NT 6.1
Endothelin receptor type B EDNRB Other 3.0
Anthrax toxin receptor 2 Antxr2 Unk 3.0
Greater expression in the TG
Microfibrillar-associated protein 4 Mfap4 Unk (20.6)
Lectin, galactose binding, soluble 7 Lgals7 AX (11.3)
MyoD family inhibitor Mdfi TX (9.6)
Suppressor of cytokine signaling 3 Socs32 ST (6.4)
RNA imprinted and accumulated in nucleus Rian Unk 6.1
Musashi homolog 2 Msi2h Other 6.0
U74 array
Neuropeptide Y receptor 1 NpyR1 NT 8.6
The principal analysis was conducted with the murine 430 array, with selected results identified using the U74A+B array set added. All listed 
transcripts showed increased expression (change p < 0.005) in two independent replicates. Fold values represent the ratio of the means of two 
determinations for each tissue. Fold changes in parentheses indicate an absent call, that is, below the statistically reliable limit of detection, in the 
lower expressing sample. Transcripts with expression levels less than 40% of the scaled mean are excluded. Superscript numerals represent the 
number of probe sets concordant for changed expression for a given gene. AX, axonogenesis; Dev, development; NT, neurotransmission; ST, signal 
transduction; Syn, synaptogenesis; TX, transcription; Unk, unknown. Greater expression in the DRG: confirmation of selected results by in situ 
hybridization and immunofluorescence appears in additional file 1. Differential expression of Ramp2 could not be confirmed by ISH. Different levels 
of Zic1 and follistatin appear to be due to high expression in the spinal cord adjacent to the DRG, rather than the DRG itself. Sostdc1 and EDNRB 
showed increased DRG expression by ISH but in a pattern more characteristic of glial than neuronal expression, with signal concentrated in nerve 
roots. The expression of RGS4 in the developing sensory ganglia has been previously described [43], and its higher expression in the DRG at E13.5 
appears to be due to the dynamic developmental regulation of this gene, rather than a persisting difference in expression between the DRG and TG. 
Greater expression in the TG: in situ hybridization confirmed some changes (see additional file 1). However, Mfap4 was widely expressed in 
embryonic tissues. Socs3 ISH exhibited relatively greater expression in the TG, but overall expression levels were low. Differential expression of 
the supressor of cytokine signaling Socs3 in the TG and DRG has previously been noted [44].
statin are increased, while a GABA receptor (Gabra2) and
neuropeptides with specific sensory roles (Galanin,
Adcyap1/PACAP) are decreased. Also reduced is latexin, a
secreted carboxypepidase inhibitor with a role in nocicep-
tion [23].
Profound changes were also observed in genes that
encode known or potential mediators of sensory neuro-
genesis, and axon growth or guidance. Increased tran-
scripts in this class included the cell adhesion molecule
Chl1, which has a known role in the growth of corticalNeural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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Selective expression of proprioceptor markers in the DRG and trigeminal system Figure 2
Selective expression of proprioceptor markers in the DRG and trigeminal system. The sensory ganglia of wild-type embryos 
were examined at E13.5 and E16.5 for the expression of transcription factors Brn3a, Etv1, Runx3 and Islet2. (a-d) At E13.5, 
Etv1 expression is restricted to the DRG, while Runx3 is expressed in both the DRG and TG. (e-h) At E16.5, Etv1 is 
expressed in both the DRG and the TG, but in the TG Etv1 positive neurons with large nuclei consistent with 1a propriocep-
tors are rare (large arrow). Instead, the majority of Etv1-positive neurons in the TG have nuclei of intermediate size and co-
express Islet2; similar cells are also found in the DRG (small arrows). The 1a proprioceptors of the DRG co-express Brn3a, 
but at relatively low levels. (i) Etv1 expression in the mesV of an E18.5 embryo expressing a tauLacZ transgene integrated into 
the Brn3a locus [42], which is thus heterozygous for Brn3a, but phenotypically normal. Numerous neurons that co-express 
Etv1 and the Brn3a-LacZ marker are noted. The caudal location and large size of these neurons are consistent with proprio-
ceptors innervating the muscles of mastication. Cb, cerebellum; chp, choroid plexus; fr, fasciculus retroflexus; IP, interpeduncu-
lar nucleus; mes5, mesencephalic trigeminal. Scale 50 μm (a-h), 400 μm (i), 50 μm (i, inset).Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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Table 2: Increased transcripts in the DRG of Brn3a knockout mouse
Transcript Symbol Class WT HT KO KO/WT
Chordin-like 1 Chrdl1 Dev 5 2 134 27.4
Musculin (MyoR) Msc TX 211 675 1,260 6.0
Insulinoma-associated 1 Insm12 TX 153 301 827 5.4
GABA transporter 1 (Gabt1) Slc6a1 NT 74 93 397 5.3
Microfibrillar-associated 4 Mfap4 Unk 112 370 559 5.0
Secretogranin II Scg2 SY 206 253 966 4.7
C-fos induced growth factor (VEGF-D) Figf Dev 76 102 319 4.2
Guanylate cyclase 1, alpha 3 Gucy1a3 ST 50 82 205 4.1
Neurogenic differentiation 6 (Math2, Nex) Neurod6 TX 83 200 344 4.1
Somatostatin Sst NT 215 382 830 3.9
Neurexin III Nrxn34 SY 367 961 1,412 3.8
Bruno-like 4 Brunol43 Other 154 274 588 3.8
Cell adhesion molecule with homology to L1CAM Chl1 AX 128 127 466 3.6
Junctophilin 1 Jph1 Other 74 119 262 3.5
Glutamate receptor, ionotropic, AMPA4 Gria43 NT 46 80 161 3.5
Glutamate receptor, ionotropic, AMPA3 Gria3 NT 40 66 138 3.5
Zinc finger homeobox 1b Zfhx1b2 TX 81 127 270 3.3
Nel-like 2 Nell2 AX 383 331 1,215 3.2
Follistatin-like 5 Fstl52 Dev 281 389 885 3.2
Disabled homolog 1 Dab12 AX 90 42 272 3.0
Mannan-binding lectin serine protease 1 Masp1 Other 95 101 282 3.0
Selected
Semaphorin 3C Sema3c2 AX 589 723 1,732 2.9
Cholecystokinin A receptor Cckar NT 95 161 269 2.8
Serotonin receptor 3A Htr3a NT 778 1,160 2,090 2.7
Homeobox A5 Hoxa5 TX 628 896 1,493 2.4
Neurogenic differentiation 1 Neurod12 TX 1,048 1,468 2,440 2.3
p21-activated kinase 3 Pak32 SY 246 270 568 2.3
Semaphorin 3D Sema3d AX 318 365 725 2.3
Protocadherin 17 Pcdh172 AX 331 340 746 2.3
Spondin 1, (f-spondin) Spon1 AX 629 778 1,413 2.2
K+ voltage-gated channel, Isk family Kcne1l NT 613 813 1,328 2.2
Deleted in colorectal carcinoma Dcc AX 93 101 200 2.2
Netrin G1 Ntng1 AX 388 556 812 2.1
Neuropilin 2 Nrp2 AX 509 485 1,063 2.1
Cadherin 22 Cdh22 AX 199 226 414 2.1
Synapsin II Syn24 SY 643 688 1,324 2.1
Glutamate receptor, ionotropic, kainate 1 Grik1 NT 221 241 455 2.1
Protocadherin 8 Pcdh82 AX 278 398 569 2.0
GDNF receptor alpha 2 Gfra2 Dev 363 436 735 2.0
Nescient helix loop helix 2 (Nscl2) Nhlh2 TX 1,222 1,996 2,446 2.0
Data for one of two independent experiments are shown. All listed transcripts showed increased expression (change p < 0.005) in two independent 
replicates. Data are complete for all replicated changes above three-fold, and selected data appear for transcripts exhibiting two- to three-fold 
change. A full data set appears in Additional file 1. Superscript numerals represent the number of probe sets concordant for changed expression for 
a given gene. AX, neurogenesis/axon growth and guidance; Dev, development; KO, knockout; NT, neurotransmission; ST, signal transduction; SY, 
synapse formation and function; TX, transcription; Unk, unknown; WT, wild type.
dendrites [24], and Nel-like 2, an epidermal growth factor
(EGF)-repeat containing factor with a previously demon-
strated role in sensory development [25]. Increased
expression was also noted for several molecules with
known or likely roles in axon guidance, including
Disabled1, Sema3c, Sema3d, f-spondin, Cadherin22, Pro-
tocadherin 8, Protocadherin 17, Dcc, and NetrinG1.
Decreased expression was noted for advillin, an actin
binding protein that is a known mediator of sensory neu-
rite outgrowth [26], as well as Ncam2 and Eph receptor
A7. These changes suggest that the profound defects
observed in the sensory axons of Brn3a null mice [17]
result from the derangement of a coordinated program of
expression of mediators of axon growth and guidance,
rather than from a single molecular lesion.
Loss of Brn3a also resulted in significant changes in the
expression of other transcription factors. Notably, dele-Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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tion of Brn3a effectively resulted in a triple-knockout of
the Pou4 homeodomain class, because Pou4f2 (Brn3b)
expression is nearly eliminated, and Pou4f3 (Brn3c)
expression is greatly reduced in Brn3a knockout ganglia.
Marked decreases were also observed in specific markers
of sensory neuron subclasses, including Prrxl1/DRG11,
Runx1 and Runx3. In contrast, specific bHLH genes,
including those encoding NeuroD1, NeuroD6, Msc, and
Nhlh2, were increased, and, perhaps consistent with this,
the inhibitory bHLH factor Id1, which can act to oppose
the action of neurogenic bHLH genes, was decreased. The
significance of some of these changes in the hierarchy of
gene regulation in developing sensory neurons is dis-
cussed below.
Loss of Brn3a expression resulted in increased expression
of essentially all of the anterior HoxA, HoxB and HoxC
genes, and the changes reached statistical significance (p <
Table 3: Transcripts decreased in the DRG of Brn3a null mice
Transcript Symbol Class WT HT KO WT/KO
Limb expression 1 Lix1 Unk 984 923 46 21.4
Vascular endothelial growth factor C Vegfc Dev 55 54 3 16.1
Neural cell adhesion molecule 2 Ncam22 AX 280 212 22 12.9
Runt related 3 Runx3 TX 251 421 22 11.3
Brn3b Pou4f2 TX 613 772 61 10.0
Brn3a Pou4f12 TX 1,107 1,119 115 9.6
Phospholipase A2, group VII Pla2g7 ST 618 438 77 8.1
K+ channel, shaker-related, member 1 Kcna13 NT 438 523 59 7.4
Advillin Avil AX 2,494 1,735 364 6.9
Galanin Gal NT 5,388 4,414 824 6.5
Basonuclin 1 Bnc1 TX 875 740 165 5.3
Insulin-like growth factor 1 Igf13 Dev 820 609 160 5.1
G protein-coupled receptor 64 Gpr642 NT 371 298 72 5.1
Adenylate cyclase activating polypeptide 1, PACAP Adcyap1 NT 283 198 57 5.0
Regulator of G-protein signaling 10 Rgs10 NT 1,793 1,596 362 5.0
Parvalbumin Pvalb ST 403 223 95 4.3
K+ channel, shaker-related, beta member 2 Kcnab2 NT 952 684 238 4.0
Diacylglycerol kinase, eta Dgkh2 ST 1,348 1,230 353 3.8
G protein-coupled receptor 73 Gpr73 NT 336 157 90 3.7
Serine proteinase inhibitor, clade A, member 3G; Spi2A Serpina3g Other 426 346 116 3.7
Copine IV Cpne4 Unk 767 636 216 3.6
PQ loop repeat containing 1 Pqlc1 Unk 911 596 259 3.5
Reticulon 4 receptor-like 2; nogo receptor-like 3 Rtn4rl2 AX 789 694 226 3.5
Spermatogenesis associated glutamate-rich protein 1 Speer1-ps1 Unk 349 307 106 3.3
Pappalysin 2 Pappa2 Other 694 794 225 3.1
Brn3c Pou4f3 TX 394 361 130 3.0
Protein tyrosine phosphatase, receptor type, J Ptprj ST 853 918 284 3.0
Docking protein 4 Dok4 ST 2,014 1655 679 3.0
Selected
Eph receptor A7 Epha7 AX 206 202 77 2.7
Latexin Lxn NT? 2,948 2,564 1,105 2.7
DRG11 Prrxl1 TX 1,514 1,339 569 2.7
Protein tyrosine phosphatase, non-receptor type 3 Ptpn3 ST 1,638 1,881 623 2.6
GABA-A receptor, subunit alpha 2 Gabra2 NT 62 90 24 2.6
Na+ channel, type VII, alpha Scn7a NT 1,199 1,386 506 2.4
Protein tyrosine phosphatase, receptor type, R Ptprr ST 3,376 3,207 1,467 2.3
Rap1, GTPase-activating protein 1 Rap1ga1 ST 1,721 1,686 749 2.3
LIM domain binding 2 Ldb2 TX 794 492 349 2.3
Anthrax toxin receptor 2 Antxr2 Unk 1,355 1,095 608 2.2
Runt related txn factor 1 Runx1 TX 360 343 162 2.2
Homeobox D1 Hoxd1 TX 852 751 404 2.1
Inhibitor of DNA binding 1 Id1 TX 1,248 1,051 624 2.0
All listed transcripts showed decreased expression (change p > 0.995) in two independent replicates. Complete data appear for all replicated 
changes above three-fold, and selected data appear for transcripts exhibiting change in the two- to three-fold range. A full data set appears in 
Additional File 2. Note that Brn3a transcripts are still detected in the Brn3a null genotype, consistent with the detection of the 3'-end of residual 
non-coding transcripts. AX, neurogenesis/axon growth and guidance; Dev, development; KO, knockout; NT, neurotransmission; ST, signal 
transduction; SY, synapse formation and function; TX, transcription; Unk, unknown; WT, wild type.Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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0.005 or p > 0.995, Materials and Methods) for seven
genes in this group (Figure 5). The posterior Hox genes
were expressed at much lower levels than the anterior fac-
tors, as expected for brachial-level DRG, and exhibited
either unchanged or decreased expression in the knock-
out. Members of the HoxD cluster were not significantly
expressed in the DRG (data not shown), with the excep-
tion of HoxD1, which, unlike the other anterior Hox gene
products, exhibited decreased expression in Brn3a null
DRG, and was also the only Hox gene product expressed
at significant levels in the TG (see additional file 3) [20].
In prior studies, we have shown that Brn3a regulates its
own expression via direct negative feedback, and that, in
heterozygous Brn3a knockout mice, partial relief of this
negative autoregulation results in increased expression of
the intact allele, resulting in nearly complete gene dosage
compensation. To determine whether gene dosage com-
pensation is also present at spinal levels, we examined the
levels of all increased and decreased transcripts in Brn3a+/
+, Brn3a+/- and Brn3a-/- ganglia (see additional files 2 and
4). In each case, the mean effect of the loss of one Brn3a
allele on target gene expression was 16% to 19% of the
effect of the loss of both alleles, compared to the 50%
change that would be expected without any compensatory
mechanism, indicating significant but incomplete com-
pensation for gene dosage.
A subset of Brn3a targets are unique to the cranial sensory 
ganglia
Comparison of the regulatory targets of Brn3a in the
developing DRG with our prior analysis of the TG [20]
suggests that there are many downstream genes in com-
mon between these ganglia. However, results from the
Target genes with increased expression in the DRG of Brn3a null mice Figure 3
Target genes with increased expression in the DRG of Brn3a null mice. (a) In situ hybridization confirms increased expression 
of Msc (musculin), NeuroD1, and Htr3a (serotonin receptor 3A) transcripts in the DRG of Brn3a wild-type and knockout 
embryos. Note that the expression of Msc in the surrounding musculature (arrows) is unchanged. (b) Immunofluorescence for 
the somatostatin-14 peptide shows increased expression concentrated in the dorsal root entry zone (arrows). The distribution 
of somatostatin-14 also reveals an abnormal accumulation of axons in the superficial dorsal horn in the Brn3a null mutant. All 
views show lower cervical (brachial) level cross-sections of E13.5 embryos. Scale: 200 μm (a), 50 μm (b).Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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Target genes with decreased expression in the DRG of Brn3a null mice Figure 4
Target genes with decreased expression in the DRG of Brn3a null mice. (a) In situ hybridization confirms decreased expression 
of multiple Brn3a downstream targets. (b) Immunofluorescence for the galanin neuropeptide shows marked reduction in the 
dorsal horn and dorsal root entry zone of Brn3a null DRG. All views show lower cervical (brachial) level cross sections of 
E13.5 embryos. Scale: 200 μm (a), 100 μm (b).Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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more advanced microarray used in the present study
(Affymetrix 430) cannot be compared directly to the prior
TG data derived from an older array (Affymetrix U74v2).
To make such a comparison, we performed an additional
analysis of these E13.5 DRG samples with the U74v2
array. We also updated the interpretation of the results for
the TG U74v2 dataset using annotations from Build 34 of
the mouse genome. This analysis confirmed that the DRG
and TG of E13.5 Brn3a knockout mice have many con-
served changes in gene expression (see additional file 3).
Transcripts increased in both the DRG and TG of Brn3a
knockout mice include the bHLH transcription factors
musculin and NeuroD1, the neurotransmitters/receptors
somatostatin, CCK-receptor A, 5HT-receptor 3A, and
GABA-transporter 1, and the growth factor FIGF/VEGF-D.
Conserved decreases include the transcription factors
Hmx1, Runx1 and basonuclin, the peptides galanin and
PACAP, as well as advillin and latexin.
Although the majority of the downstream targets of Brn3a
were conserved in the DRG and TG, a subset of genes was
uniquely regulated at each axial level. The most profound
differences were observed for a set of genes markedly
increased in the TG of Brn3a knockout embryos, and
unchanged in the DRG (Figure 6). These differentially reg-
ulated genes include those encoding the transcription fac-
tors Tcfap2b (Ap2β), NeuroD4 (Math3) and Gata3, the
calcium binding protein Calb2 (calretinin) and the small
GTP-binding protein Rab3b. These results led us to con-
sider possible mechanisms for cell-specific target gene reg-
ulation by Brn3a in these two closely related neural
tissues.
The cell-type specific effects of transcription factors are
generally attributed to distinct complements of interact-
ing partners, or to the expression of related factors that
provide redundancy in some cell types but not in others.
However, with the exception of the Hox factors, the very
similar gene expression profiles of the DRG and TG do not
suggest many candidates for distinct Brn3a partners in
these neurons. In addition, the loss of Brn3a effectively
eliminates expression of all Pou4 class factors in both the
DRG and TG, making selective redundancy unlikely.
One approach to understanding the cell-specific effects of
the loss of Brn3a expression is suggested by recent work in
which we have demonstrated a correlation between Brn3a
binding to its target sites in vivo and H3-acetylation in the
vicinity of the potential binding sites [[27] in press].
Given these results, one potential mechanism for the dif-
ferential regulation of target genes by Brn3a might be dis-
tinct modifications of chromatin at the target gene loci in
the DRG and TG, which could modulate the effects of
Brn3a or downstream regulatory factors. To examine this
question for the differentially regulated loci Tcfap2b,
NeuroD4 and Gata3, we used chromatin immunoprecip-
itation (ChIP) to profile histone H3 acetylation in wild-
type E13.5 DRG and TG (Figure 7). We also examined the
Msc locus as an example of a gene that shows similarly
increased expression in the DRG and TG of Brn3a knock-
out mice. ChIP assays of the promoter regions of three
constitutively expressed genes, Gapdh,  Mapt  (tau), and
Eno2 (neuron specific enolase), were used as positive con-
Brn3a regulation of Hox gene expression in the DRG Figure 5
Brn3a regulation of Hox gene expression in the DRG. Hox 
gene expression data were derived from 430A+B array data 
for E13.5 Brn3a wild-type (wt) and knockout (ko) DRG. Sta-
tistically significant increases (p < 0.005) in the knockout 
were observed for 7 anterior Hox transcripts, and significant 
decreases were observed (p > 0.995) for two posterior Hox 
transcripts (asterisks). Similar changes reached statistical sig-
nificance for 5 anterior Hox genes and one posterior Hox 
gene in a replicate assay. HoxA7 (parentheses) did not reach 
statistical significance for detection, indicating high back-
ground signal in this probe set. Legend: n.g., no gene at the 
corresponding position in the cluster; n.d., not determined.Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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trols, and the results were normalized to negative control
assays from the promoter region of the Alb1 (albumin)
gene, which is not expressed in the nervous system.
Because the genomic sequences that regulate these genes
in the sensory ganglia have not been defined, we surveyed
histone acetylation across these loci using multiple oligo-
nucleotide pairs spaced at 500 to 1,000 base-pair (bp)
intervals from approximately -10 kb to +15 kb relative to
the start of transcription, using quantitative real-time PCR
('locus-ChIP') ["locus-ChIP", [27] in press].
ChIP profiling of the Msc locus revealed similar levels of
H3-acetylation in the DRG and TG. However, ChIP assays
of the Tcfap2b  and  NeuroD4  loci revealed significantly
greater H3-acetylation in the TG relative to the DRG (p =
0.0003 and p  = 0.0005, respectively), while the Gata3
locus exhibited a trend (p = 0.09) toward greater acetyla-
tion in the TG. As expected, the positive control promoters
were highly acetylated, and the negative control, Alb1, was
deacetylated in both the DRG and TG. Thus, the state of
H3-acetylation in wild-type ganglia appears to be corre-
lated both with basal expression and also with a state of
latent potential expression that can be induced in Brn3a
null ganglia.
Discussion
Numerous transcription factors have been shown to play
key roles in the differentiation of brainstem, spinal, and
spinal sensory neurons, yet, for the most part, the pro-
grams of gene expression regulated by these factors
remain unknown. A layer of complexity is added to the
analysis of the downstream targets of these factors by the
fact that their expression patterns are often very complex,
and may include diverse classes of neurons and non-neu-
ronal cell types with no obvious common characteristics.
Brn3a, for example, is expressed in a majority of differen-
tiating peripheral sensory neurons, and also in specific
neurons of the spinal cord, olivo-cerebellar system, mid-
brain, diencephalon and retina. The LIM-domain tran-
scription factor Islet1 is co-expressed with Brn3a in the
sensory system [10], but in the CNS it is expressed prima-
rily in motor neurons [28,29], and also has important
roles in the development of the heart [30] and pancreatic
islet cells [31]. A fundamental unanswered question is
whether these factors, and many others with expression
patterns of similar complexity, regulate the same down-
stream targets in different neuronal types, and in neurons
versus non-neuronal cells.
To better understand the molecular pathways of sensory
development, we initiated the present study by examining
global gene expression in the brachial-level DRG and TG
at E13.5. At this stage, when essentially all sensory neu-
rons have exited the cell cycle and markers of sensory sub-
types are beginning to be expressed, the gene expression
patterns of the DRG and TG are quite similar. Some tran-
scripts exhibit quantitative differences between the gan-
glia, which may represent relative differences in cellular
composition or the timetable of development, but very
few transcripts are uniquely expressed in either the DRG
or TG. Most prominent among the few transcripts
Trigeminal-specific targets of Brn3a regulation Figure 6
Trigeminal-specific targets of Brn3a regulation. (a) TG data 
from a previously published data set [20]. (b) DRG data from 
the present study. Brn3a wild-type (WT), heterozygote (Het) 
and knockout (KO) E13.5 DRG were analyzed for global 
gene expression using U74Av2+U74v2B arrays to allow 
direct comparison with the prior analysis of the embryonic 
TG (Additional file 3). Msc, shown for comparison, exhibits 
markedly increased expression in the DRG and TG of Brn3a 
knockout mice, while Gata3, Tcfab2b, Calb2, Rab3b and 
Neurod4 are increased only in the DRG. Changes in Msc, 
Gata3, Tcfap2b, Calb2 and NeuroD4 have been previously 
verified in the TG of Brn3a knockout mice by in situ hybridi-
zation or immunofluorescence [20]. Rab3b is newly identified 
as a Brn3a target in the TG due to progress in the annotation 
of the mouse genome. Gene abbreviations in parentheses 
indicate expression below the statistically significant thresh-
old of detection (absent call) in all three genotypes.Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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Acetyl-histone H3 profiling of Brn3a target gene loci Figure 7
Acetyl-histone H3 profiling of Brn3a target gene loci. Histone H3 acetylation was assayed using ChIP and tiled PCR primer 
pairs from -10 kb to 15 kb of the Msc, Tcfap2b, NeuroD4 and Gata3 gene loci. Positive controls for these assays included primer 
pairs located in the promoter regions of the Mapt (tau), Gapdh, and Eno2 loci, which are highly expressed in the DRG and TG 
and are unchanged in Brn3a null mice. The silent alb1 locus was used as a negative control and to set the baseline of one-fold 
enrichment (yellow line). H3 acetylation of these loci in chromatin samples from the E13.5 DRG and TG were compared by t-
tests using fold enrichment values for primer pairs flanking the transcription start site of each locus (points shown in red). H3 
acetylation was not significantly different at the msc locus (p = 0.25), while Tcfap2b (p = 0.0003) and NeuroD4 (p = 0.0005) 
showed significantly greater acetylation in the TG, and Gata3 (p = 0.09) showed a trend toward greater acetylation in the TG. 
UTR, untranslated region.Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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restricted to a particular axial level are those encoded by
the Hox genes and Etv1, which at this stage are expressed
only in the DRG. The restriction of the Hox transcripts
(with the exception of HoxD1) to spinal levels is expected
based on the well characterized axial expression pattern of
these genes. Etv1 expression is restricted to the DRG at
E13.5 because the first neurons to express this marker, the
large proprioceptive neurons innervating muscle spindles,
develop within the DRG at spinal levels but at cranial lev-
els are largely sequestered in the mesV. Etv1-expressing
neurons that develop in the TG by E16.5 are distinguished
by smaller size and the co-expression of Islet2, and appear
to represent a distinct subset of sensory neurons.
Global analysis of gene expression in Brn3a knockout and
wild-type DRG demonstrates that Brn3a regulates, directly
or indirectly, an extensive program of gene expression.
Advances in microarray technology and in the annotation
of the mouse genome have allowed us to significantly
expand the number of identified Brn3a targets from a
prior study of the TG [20]. A large number of the down-
stream targets of Brn3a in the DRG have known roles in
neurogenesis or neural function, and include components
of axons and synapses, neurotransmitters and their recep-
tors, mediators of intracellular signaling, and transcrip-
tion factors. Because the regulatory sequences of many of
these genes have not been described, in many cases it is
not possible to distinguish direct regulatory targets from
secondary or compensatory effects. However, in recent
studies we have used locus-ChIP to demonstrate that
Brn3a is a direct repressor of NeuroD1 and NeuroD4 in
the embryonic TG [[27] in press], as well as a negative
modulator of its own expression [32,33].
Most Brn3a target genes are conserved between sensory
neurons at cranial and spinal levels. However, a subset of
genes with the most increased expression in the TG do not
change expression in the Brn3a knockout DRG, and are
generally undetectable in the E13.5 DRG of animals of
any genotype. These differentially regulated transcripts
include the transcription factors Tcfap2b, Gata3 and
NeuroD4, the calcium binding protein calbindin2 (cal-
retinin), and the small GTP-binding protein Rab3b,
implicated in synaptic vesicle release [34]. Because there
are normally few transcripts that distinguish the TG from
the DRG at this stage of development, the gene expression
patterns of the DRG and TG are significantly more differ-
ent in Brn3a knockout ganglia than in the wild type. This
suggests that one important role for Brn3a is to suppress
potential differences in gene expression between the spi-
nal and cranial ganglia, mediating a process of 'conver-
gent development' in which functionally similar
populations of neurons are generated from different
embryological sources.
The state of histone H3 acetylation of Brn3a target gene
loci offers some insight into the underlying mechanism of
the differential regulation of these targets at spinal and
cranial levels. Normally, H3 acetylation is associated with
the regulatory sequences in the promoters of actively tran-
scribed genes. Consistent with this, we have previously
shown that the promoter region of Pou4f1 itself is highly
acetylated in the TG, and the promoters of genes that are
silent in the sensory ganglia regardless of Brn3a genotype
are deacetylated [[27] in press]. In wild-type DRG and TG,
the differentially regulated genes NeuroD4 and Tcfap2b are
nearly silent, yet these gene loci can be distinguished in
trigeminal neurons by increased H3 acetylation over a
region encompassing the transcription start site. The Msc
gene is also normally silent, but it exhibits increased
expression at both cranial and spinal levels in Brn3a null
mice, and is accordingly H3 acetylated in both the DRG
and TG. Thus, in the case of these genes with increased
expression in the Brn3a knockout, H3 acetylation appears
to reveal a latent state of potential expression, which is
normally repressed by Brn3a or its downstream effectors,
and de-repressed in Brn3a knockout ganglia.
The failure of DRG neurons to increase NeuroD4  and
Tcfap2b  expression in Brn3a knockout ganglia suggests
that a redundant mechanism of repression exists for these
genes at spinal but not cranial levels. The action of such a
repressor may be reflected in the low levels of histone
acetylation at these loci in the DRG. Because the most
prominent distinguishing feature of sensory gene expres-
sion at spinal levels is the expression of multiple Hox
genes, these factors are candidate mediators of this selec-
tive repression of NeuroD4 and Tcfap2b in the DRG. Tran-
scriptional repressor functions have been described for
the Hox genes [35], and there is evidence that Hox pro-
teins can directly block the activity of the widely expressed
histone acetyltransferase CBP-p300 [36]. Hox gene repres-
sion of a subset of Brn3a target gene loci could be an active
process at E13.5, or Hox gene expression at earlier devel-
opmental stages could produce persisting modifications
of chromatin, reflected in the deacetylation of these loci
observed here, resulting in reduced transcription even
when direct repression by Hox genes is no longer active.
Materials and methods
Matings, embryos, and RNA isolation for array analysis
To generate tissue for microarray analysis, timed matings
of Brn3a heterozygote animals were performed, and the
embryos were harvested at E13.5. Only embryos corre-
sponding to E13.5 ± 0.5 days based on the staging system
of Theiler [37] were used for microarray analysis. TG were
removed by blunt dissection and carefully freed of adher-
ent non-neural tissue with fine forceps. DRG were isolated
by stripping of the spinal cord with its adherent ganglia,
followed by dissection of the ganglia with fine forceps.Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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DRG were harvested from brachial region only, including
the C5-T1 levels. Dissected ganglia were placed in RNAse
inhibitor solution (RNAlater, Ambion, Austin TX), and
RNA was prepared using the RNeasy system (Qiagen,
Valencia, CA). Embryos were genotyped for Brn3a alleles
as previously described [17] from a sample of tail or hind-
limb tissue harvested at the time of ganglion dissection.
Genotyped TG or DRG from five embryos were sufficient
to provide approximately 5 μg of total RNA for a single
microarray analysis. The generation of cDNA, production
of labeled cRNA, and hybridization to GeneChip arrays
were all performed according to standard protocols pro-
vided by the manufacturer (Affymetrix, Santa Clara, CA).
Analysis of expression array data
The principal microarray datasets presented here for the
mouse DRG and TG were generated using the Affymetrix
430A and 430B microarrays. In addition, the same DRG
samples were analyzed using Affymetrix U74A and U74B
arrays for direct comparison with prior data sets for the TG
[20]. The primary analysis of microarray data, including
determination of the absence/presence of the assayed
transcripts, transcript expression levels, and the probabil-
ity of change in transcript expression between samples
('change  p') was performed with Microarray Suite 5.0
(Affymetrix). Default Microarray Suite 5.0 parameters
were used for increase (I) and decrease (D) calls. For the
430 array set these cutoff values were p < 0.005 and p >
0.995 for I and D, respectively, and for the U74 arrays, the
values were p < 0.003 and p > 0.997. All array values were
initially scaled to a mean value of 500 using global scal-
ing. To permit more meaningful comparison of the
expression levels of transcripts assayed by the 430A and
430B arrays, the initial expression values for the 430B
array were rescaled based on the expression levels of 100
probe sets in common between the 430A and 430B arrays.
Microarray probe sets were related to the corresponding
mouse transcripts using the NetAffx database (Affyme-
trix), based on the NCBI Build 34 annotation of the
mouse genome. The array data discussed in this publica-
tion have been deposited in NCBI's Gene Expression
Omnibus (GEO) [38] and are accessible through GEO
series accession number GSE5658.
Comparisons of gene expression between wild-type DRG
and TG (Table 1) and between the DRG from Brn3a wild-
type, heterozygous, and knockout mice (Tables 2 and 3)
were performed in duplicate, using separate pools of iso-
lated ganglia. To be included in the tables of changed tran-
scripts for a given tissue or genotype, the following criteria
were met: both replicates were called as 'present' in the
condition of greater expression; both replicates exhibited
an increased or 'I' call for the condition of higher expres-
sion; and the probe set identified an annotated and
named transcript in NCBI Build 34 of the mouse genome.
Duplicate probe sets identifying the same transcript were
eliminated, and the tables are annotated with the number
of concordant probe sets for each transcript. Concordance
was identified by the agreement of the present and
increased calls for the duplicate probe set, and a mini-
mum fold change of 2.0. In the case of multiple concord-
ant probe sets, the probe set with the greatest fold change
is listed in the tables. Results for the probe sets meeting
the inclusion criteria were ranked by fold change, and the
cutoff value for inclusion appears in the tables.
In situ hybridization and immunofluorescence
Non-isotopic in situ hybridization was performed as pre-
viously described [38]. A list of probes used and their
sources appears in additional file 5. Immunofluorescence
for Brn3a was performed with rabbit polyclonal antisera
as previously as previously described [39]. Other antisera
used included rabbit antisera against Etv1/Er81 and
Runx3 obtained from Dr Sylvia Arber [13,15], and guinea
pig antisera against Islet2, obtained from Dr Sam Pfaff
[28]. Immunofluorescence for other antigens was per-
formed with commercially available antibodies, including
rabbit anti-calretinin (Swant, Bellinzona, Switzerland),
rabbit anti-galanin (Bachem, King of Prussia, PA), rabbit
anti-somatostatin-14 (Peninsula Laboratories), and goat
anti-β-galactosidase (Biogenesis (MorphoSys), Kingston,
NH).
Locus-wide chromatin immunoprecipitation
Locus-ChIP assays were performed as previously
described [[27] in press]. In brief, embryos for ChIP assays
were generated from timed matings of ICR mice. DRG and
TG were dissected from E13.5 embryos and fixed in 4%
paraformaldehyde for 30 minutes, then quenched with
150 mM glycine. The fixed tissue was washed with phos-
phate-buffered saline and stored at -80°C until analysis.
Selection of chromatin complexes from embryonic sen-
sory ganglia was performed by a modification of a widely
used procedure [40]. For each analysis, fixed ganglia from
30 embryos (60 TG or approximately 300 DRG) were
pooled and suspended in lysis buffer containing 50 mM
Tris-HCl, pH 8.1, with 10 mM EDTA and 1% SDS, 1 mM
4-(2-Aminoethyl)benzenesulfonylfluoride, HCl (AEBSF)
and a proprietary protease inhibitor mix (1 × Complete
Mini, Roche, Indianapolis, IN; used according to instruc-
tions). Chromatin was then fragmented to an average size
of 500 bp by sonication, and insoluble cellular debris was
removed by centrifugation. The supernatant containing
fragmented chromatin was diluted in 15 mM Tris-HCl,
pH 8.1, with 150 mM NaCl, 1 mM EDTA, 1% Triton-X-
100, 0.01% SDS, and protease inhibitor mix. An unse-
lected ('input') sample of 10% of the total homogenate
was removed prior to antibody selection.Neural Development 2007, 2:3 http://www.neuraldevelopment.com/content/2/1/3
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ChIP was performed using rabbit anti-acetylated histone
H3 antibody (Upstate Biotechnology, Inc., Bellerica, MA,
catalog no. 06–599), which recognizes histone H3
acetylated at lys9 and lys14. For each selection, 50 μg of
anti-histone antibody was coupled to 250 μL of anti-rab-
bit IgG magnetic beads (Dynal M-280), in lysis buffer con-
taining 50 mM Tris-HCl, pH 8.1, with 10 mM EDTA and
1% SDS. To reduce non-specific background, the chroma-
tin sample was pre-cleared using the magnetic beads with
the secondary antibody alone. The sample was then incu-
bated overnight with secondary antibody-coupled beads
to select the acetyl H3-containing chromatin complexes.
The beads were then washed for 5 minutes at room tem-
perature with each of the following solutions: 20 mM Tris-
HCl, pH 8.1, with 150 mM NaCl, 2 mM EDTA, 0.1 % SDS,
and 1% Triton-X-100; 20 mM Tris-HCl, pH 8.1, with 500
mM NaCl, 2 mM EDTA, 0.1% SDS, and 1% Triton-X-100;
10 mM Tris-HCl, pH 8.1, with 1 mM EDTA, 0.25 M LiCl,
1% NP-40, and 1% deoxycholate. Salt and detergent were
removed by washing twice with 10 mM Tris-HCl, 1 mM
EDTA, pH 8. DNA was extracted from the antibody-chro-
matin complexes and the input sample by heating in 0.1
M NaHCO3 with 200 mM NaCl and 1% SDS at 65°C for
4 hours with constant shaking. The input and selected
samples were then digested with proteinase K, extracted
with phenol/chloroform, and precipitated with ethanol.
Real-time locus-wide PCR analysis
Chromatin fragments recovered from the immunoprecip-
itated and input samples were then assayed by real-time
PCR using an ABI 7300 thermocycler and SYBR Green
fluorimetric detection. To screen an entire gene locus, oli-
gonucleotide pairs were designed at 500 to 1,000 bp inter-
vals throughout the region, and selected and unselected
samples were run in parallel in a 96-well plate format. The
primer pairs used for locus-ChIP assays of the NeuroD4,
Msc, Tcfap2b and Gata3 loci appear in additional file 5.
The enrichment of immunoprecipitated chromatin frag-
ments was assayed by the cycle-threshold difference
method [41]. For this method, real-time PCR signals are
measured using the 'cycle threshold', or Ct parameter,
which is the number of cycles required for the amplifica-
tion product to reach an arbitrary level of fluorescence
intensity (threshold), and is logarithmic to the initial
abundance of the target sequence in the sample. For each
PCR amplicon, a ΔCt value comparing the unselected
(input) and antibody-selected DNA samples was then cal-
culated by subtracting the Ctselected from the Ctinput signal:
ΔCt = Ctinput - Ctselected
Fold enrichment values for target sequences bound by the
selecting antibodies, corresponding to the y-axis of the
locus-ChIP plots, were calculated using the following
equation:
E = 2(ΔCt-ΔCtcontrol)
Because product formation approximately doubles with
each cycle in the linear range of amplification, a ΔCt of
one cycle represents a two-fold difference in starting tem-
plate. A significant advantage of this method is that, for
each primer pair, a selected sample is compared directly to
its unselected control, which differs only by the antibody
selection process. Potentially confounding factors such as
small differences in the PCR amplification efficiency of
different primer pairs are eliminated in this comparison.
The ΔCt assays for each pool of selected material were nor-
malized to an arbitrary baseline (one-fold enrichment)
determined using two primer pairs in the promoter region
of the Alb1 (albumin locus), which was chosen as a nega-
tive control because it is not transcribed in the nervous
system. Fold enrichment values for the Alb1 locus were
very similar to values for the unselected, intergenic
regions of the target gene loci. Primer pairs in the pro-
moter regions of Mapt  (microtubule-associated protein
tau) and Eno2 (neuron specific enolase), which exhibit tis-
sue specific expression in the nervous system, and Gapdh
(glyceraldehyde-3-phosphate dehydrogenase), which is
expressed ubiquitously, were used as positive controls.
Comparisons of histone H3 acetylation at a given locus in
the DRG and TG were made using three- to six-fold
enrichment values using oligonucleotide pairs in a contig-
uous genomic region near the transcription start site of the
analyzed gene loci. The statistical significance (p values) of
the difference in H3 acetylation was determined using
two-sample, unequal variance t-tests.
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